Q1 Interim Report July 2024 – September 2024

Hamlet Biopharma
|
November 7, 2025
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2025
Hamlet BioPharma.